Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.89)
# 666
Out of 5,046 analysts
466
Total ratings
45.73%
Success rate
11.46%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Maintains: Buy | $3 → $52 | $24.11 | +115.68% | 15 | Oct 29, 2025 | |
| IPHA Innate Pharma | Upgrades: Buy | $5 | $1.98 | +152.53% | 18 | Oct 29, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Buy | $9 → $22 | $4.75 | +363.16% | 2 | Oct 29, 2025 | |
| DYAI Dyadic International | Assumes: Buy | $3 | $1.16 | +158.62% | 1 | Oct 23, 2025 | |
| CELC Celcuity | Maintains: Buy | $66 → $77 | $77.16 | -0.21% | 10 | Oct 22, 2025 | |
| DCTH Delcath Systems | Maintains: Buy | $31 → $30 | $9.83 | +205.19% | 15 | Oct 20, 2025 | |
| CORT Corcept Therapeutics | Reiterates: Buy | $145 | $73.47 | +97.36% | 24 | Oct 20, 2025 | |
| EVAX Evaxion | Reiterates: Buy | $16 | $5.75 | +178.26% | 14 | Oct 20, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $6.64 | +201.25% | 3 | Sep 23, 2025 | |
| DNTH Dianthus Therapeutics | Reiterates: Buy | $40 | $34.98 | +14.35% | 7 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $9.64 | -11.83% | 17 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.16 | +409.26% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.5 | $4.14 | +105.31% | 13 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.56 | +40.45% | 10 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $5.26 | +185.17% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3.5 | $4.04 | -13.37% | 17 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.67 | +79.64% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $80 | $72.65 | +10.12% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $130 | $99.32 | +30.89% | 4 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.56 | +348.72% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $18.01 | +94.34% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $31 | $18.27 | +69.68% | 19 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $2.15 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.11 | +170.27% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.54 | +29.87% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $60 | $5.39 | +1,013.17% | 15 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $2.13 | +64.32% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.14 | +787.85% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.45 | - | 15 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.28 | +63.55% | 14 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.95 | +9,130.77% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $5.04 | +396.03% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $0.62 | +2,005.26% | 7 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $28.71 | +143.82% | 12 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $35.06 | +71.14% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $8.07 | +308.92% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.73 | +584.74% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.92 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.65 | +43.79% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.96 | +575.68% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.39 | +66.98% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.72 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.37 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.63 | +453.85% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.95 | +1,182.05% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.78 | +180.90% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $3.39 | +3,439.82% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $1.44 | +733.33% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.70 | +2,759.59% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $16.93 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $8.04 | -25.37% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.83 | +719.67% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $9.45 | +249.21% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $18.99 | -49.97% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.30 | +1,076,823.08% | 1 | Mar 5, 2020 |
Vor Biopharma
Oct 29, 2025
Maintains: Buy
Price Target: $3 → $52
Current: $24.11
Upside: +115.68%
Innate Pharma
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.98
Upside: +152.53%
Unicycive Therapeutics
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $4.75
Upside: +363.16%
Dyadic International
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $1.16
Upside: +158.62%
Celcuity
Oct 22, 2025
Maintains: Buy
Price Target: $66 → $77
Current: $77.16
Upside: -0.21%
Delcath Systems
Oct 20, 2025
Maintains: Buy
Price Target: $31 → $30
Current: $9.83
Upside: +205.19%
Corcept Therapeutics
Oct 20, 2025
Reiterates: Buy
Price Target: $145
Current: $73.47
Upside: +97.36%
Evaxion
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $5.75
Upside: +178.26%
Actuate Therapeutics
Sep 23, 2025
Reiterates: Buy
Price Target: $20
Current: $6.64
Upside: +201.25%
Dianthus Therapeutics
Sep 8, 2025
Reiterates: Buy
Price Target: $40
Current: $34.98
Upside: +14.35%
Sep 8, 2025
Reiterates: Buy
Price Target: $8.5
Current: $9.64
Upside: -11.83%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $2.16
Upside: +409.26%
Aug 19, 2025
Reiterates: Buy
Price Target: $8.5
Current: $4.14
Upside: +105.31%
Aug 19, 2025
Reiterates: Buy
Price Target: $5
Current: $3.56
Upside: +40.45%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $5.26
Upside: +185.17%
Aug 13, 2025
Maintains: Buy
Price Target: $7 → $3.5
Current: $4.04
Upside: -13.37%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.67
Upside: +79.64%
Aug 7, 2025
Maintains: Buy
Price Target: $73 → $80
Current: $72.65
Upside: +10.12%
Jun 24, 2025
Maintains: Buy
Price Target: $110 → $130
Current: $99.32
Upside: +30.89%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.56
Upside: +348.72%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $18.01
Upside: +94.34%
May 22, 2025
Maintains: Buy
Price Target: $25 → $31
Current: $18.27
Upside: +69.68%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $2.15
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $1.11
Upside: +170.27%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.54
Upside: +29.87%
May 6, 2025
Maintains: Buy
Price Target: $135 → $60
Current: $5.39
Upside: +1,013.17%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $2.13
Upside: +64.32%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $2.14
Upside: +787.85%
Mar 27, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.45
Upside: -
Mar 19, 2025
Reiterates: Buy
Price Target: $7
Current: $4.28
Upside: +63.55%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.95
Upside: +9,130.77%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $5.04
Upside: +396.03%
Mar 11, 2025
Reiterates: Buy
Price Target: $13
Current: $0.62
Upside: +2,005.26%
Mar 3, 2025
Reiterates: Buy
Price Target: $70
Current: $28.71
Upside: +143.82%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $35.06
Upside: +71.14%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $8.07
Upside: +308.92%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.73
Upside: +584.74%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.92
Upside: -
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.65
Upside: +43.79%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $2.96
Upside: +575.68%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.39
Upside: +66.98%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.72
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.37
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $1.63
Upside: +453.85%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.95
Upside: +1,182.05%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.78
Upside: +180.90%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $3.39
Upside: +3,439.82%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $1.44
Upside: +733.33%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.70
Upside: +2,759.59%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $16.93
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $8.04
Upside: -25.37%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.83
Upside: +719.67%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $9.45
Upside: +249.21%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $18.99
Upside: -49.97%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.30
Upside: +1,076,823.08%